Curated News
By: NewsRamp Editorial Staff
June 25, 2026
Medical Resource Association Announces Science in the City International – Paris 2026
TLDR
- Medical Resource Association's Paris 2026 symposium offers a strategic advantage in navigating France's evolving medical cannabis framework.
- Science in the City International - Paris 2026 convenes global experts to advance evidence-based cannabinoid medicine through physician education and clinical integration.
- The symposium fosters cross-border collaboration to improve patient outcomes and responsible access to cannabinoid therapeutics worldwide.
- A simulcast from New York will connect international audiences, expanding the reach of this pivotal medical cannabis event.
Impact - Why it Matters
This news matters because it highlights a critical juncture in the evolution of medical cannabis in France and Europe. As France moves toward a permanent medical cannabis framework, this symposium provides a vital platform for global experts to collaborate on evidence-based medicine, physician education, and responsible patient access. For healthcare professionals, researchers, and patients, this event could shape future treatment options and regulatory policies, directly impacting the availability and quality of cannabinoid therapeutics. It underscores the importance of cross-border innovation and scientific exchange in advancing healthcare.
Summary
The Medical Resource Association has announced the Third Annual Science in the City International - Paris 2026, a premier international symposium focusing on cannabinoid therapeutics, physician education, and clinical integration. This event will gather global leaders in medicine, research, pharmacy, regulation, and industry at a crucial time as France progresses toward a permanent medical cannabis framework. Building on successful Bordeaux editions, the move to Paris underscores France's growing role in cannabinoid medicine and pharmaceutical innovation in Europe.
The symposium aims to accelerate evidence-based medicine and patient access by bringing together physicians, researchers, prescribers, pharmacists, healthcare executives, regulators, industry innovators, and patient advocates. Key figures from the Medical Resource Association, including COO Charles S. Messal, CFO Timothy L. Beury, and Founder and CEO Kristen M. Beury, emphasize the importance of scientific collaboration and education during this transformative period. The event will also feature a "Live from New York" global simulcast to enhance cross-border scientific exchange.
Registration is now open for physicians, researchers, pharmacists, and other stakeholders committed to advancing cannabinoid medicine. The symposium represents a pivotal moment for France and Europe, offering a platform to shape the future of pharmaceutical innovation and therapeutic development. For more information, contact Charles Stéphane Messal via email or phone.
Source Statement
This curated news summary relied on content disributed by Newsworthy.ai. Read the original source here, Medical Resource Association Announces Science in the City International – Paris 2026
